An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats

Metabolism: Clinical and Experimental

Volumn 45, Issue 3, 1996, Pages 320-327

  Berti Mattera, Liliana ^a   Day, Nancy ^b   Peterson, Richard G ^d   Eichberg, Joseph ^c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; INOSITOL; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; POLYPHOSPHOINOSITIDE; SORBINIL; SORBITOL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME INHIBITION; MALE; NONHUMAN; PERIPHERAL NERVE; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 0029947530     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90285-1     Document Type: Article

References (35)

1. Greene DA, Lattimer-Greene SA, Sima AAF: Pathogenesis of diabetic neuropathy: Role of altered phosphoinositide metabolism. Crit Rev Neurobiol 5:143-219, 1989
2. Greene DA, Lattimer SA: Impaired rat sciatic nerve sodiumpotassium adenosine triphosphatase in acute streptozotocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest 72:1058-1063, 1983
3. Mayer JH, Tomlinson DR: Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocindiabetic rats. Diabetologia 25:433-438, 1983
4. Simpson CMF, Hawthorne JN: Reduced Na,K-ATPase activity in peripheral nerve of streptozotocin-induced diabetic rats: A role for protein kinase C? Diabetologia 31:297-303, 1988
5. Tomlinson DR, Stevens EJ, Diemel LT: Aldose reductase inhibitors and their potential for treatment of diabetic complications. Trends Pharmacol Sci 15:193-197, 1994
6. Greene DA, Lattimer S, Sima AAF: Sorbitol, phosphoinositides and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316:599-606, 1987
7. Berti-Mattera LN, Goraya T, Douglas JG, et al: Diminished receptor-mediated phosphoinositide breakdown and reduced adenylyl cyclase activity accompany altered G protein levels in diabetic nerve. Diabetes 41:22A, 1992 (suppl 1, abstr)
8. Zhu X, Eichberg J: 1,2-Diacylglycerol content and its arachidonoyl-containing molecular species are reduced in sciatic nerve from streptozotocin-induced diabetic rats. J Neurochem 55:1087-1090, 1990
9. Ido Y, McHowat J, Chang KC, et al: Neural dysfunction and metabolic imbalances in diabetic rats: Prevention by acetyl-L-carnitine. Diabetes 43:1469-1477, 1994
10. Borghini I, Ania-Laheurarta A, Regazzi R, et al: α, βI, βII, δ and ε protein kinase C isoforms and compound activity in the sciatic nerve of normal and diabetic rats. J Neurochem 62:686-696, 1994
11. Borghini I, Geering K, Gjnouci A, et al: In vivo phosphorylation of the Na,K-ATPase alpha subunit in sciatic nerve of control and diabetic rats: Effects of protein kinase modulators. Proc Natl Acad Sci USA 91:6211-6215, 1994
12. Kim J, Rushovich EH, Thomas TP, et al: Diminished specific activity of cytosolic protein kinase C in sciatic nerve of streptozotocin-induced diabetic rats and its correction by dietary myo-inositol. Diabetes 40:1545-1554, 1991
13. Tomlinson DR, Ettlinger CB, Lockett MJ: Modulation of the sodium/potassium pump of peripheral nerve-Pharmacological manipulation of protein kinase C. Mol Neuropharmacol 3:133-138, 1993
14. +-ATPase activity in diabetic nerve by protein kinase C agonists. Am J Physiol 256:E264-E269, 1989
15. Michell RH, Drummond A, Downes CP: Inositol Lipids in Cell Signalling. London, UK, Academic, 1989
16. Eichberg J, Dawson RMC: Polyphosphoinositides in myelin. Biochem J 96:644-650, 1965
17. Sheltawy A, Dawson RMC: The metabolism of polyphosphoinositides in hen brain and sciatic nerve. Biochem J 111:157-165, 1969
18. Bell ME, Peterson RG, Eichberg J: Metabolism of phospholipids in peripheral nerve from rats with chronic streptozotocin-induced diabetes: Increased turnover of phosphatidylinositol-4,5-bisphosphate. J Neurochem 39:192-200, 1982
19. Berti-Mattera LN, Lowery J, Day S-F, et al: Alterations in phosphoinositide metabolism, protein phosphorylation and carbohydrate levels in sciatic nerve from Wistar fatty diabetic rats. Diabetes 38:373-378, 1989
20. Lowery JM, Berti-Mattera LN, Zhu XI, et al: Relationship of ATP turnover, polyphosphoinositide metabolism and protein phosphorylation in sciatic nerve and derived peripheral myelin subfractions from normal and streptozotocin diabetic rats. J Neurochem 52:921-932, 1989
21. Eichberg J, Mathew J, Fox D, et al: Phosphoinositide metabolism and Na,K-ATPase activity are altered in nerve and retina from the Zucker diabetic fatty rat (ZDF/Gmi-fa). Diabetes 42:101A, 1993 (suppl 1, abstr)
22. 32P into polyphosphoinositides in peripheral nerve of the streptozotocin diabetic rat. J Neurochem 47:1932-1935, 1986
23. Whiteley SJ, Tomlinson DR: Motor nerve conduction velocity and nerve polyols in mice with short term genetic or streptozotocin-induced diabetes. Exp Neurol 80:314-321, 1985
24. Berti-Mattera LN, Eichberg J: Phospholipid metabolism and protein phosphorylation in sciatic nerve from genetically diabetic (db/db) mouse. Diabetes 37:1703-1707, 1988
25. Bagnasco SM, Murphy HR, Bedford JJ, et al: Predominant osmotically active organic solutes in rat and rabbit medullas. J Biol Chem 261:5872-5877, 1986
26. Burg MB, Kador PF: Sorbitol, osmoregulation, and the complications of diabetes. J Clin Invest 81:635-640, 1988
27. Stevens MJ, Lattimer SA, Kamijo M, et al: Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia 36:608-614, 1993
28. 32P into polyphosphoinositides and other phospholipids in peripheral nerve of the streptozotocin diabetic rat. J Neurochem 45:1692-1698, 1985
29. Hothersall JA, McLean P: Effect of experimental diabetes and insulin on phosphatidylinositol synthesis in rat sciatic nerve. Biochem Biophys Res Commun 88:477-484, 1979
30. 3H]glycerol into glycerolipids of sciatic nerve from the streptozotocin diabetic rat. J Neurochem 45:465-469, 1985
31. Zhu X, Eichberg J: A pool of myo-inositol needed for phosphatidylinositol synthesis is depleted in diabetic nerve. Proc Natl Acad Sci USA 87:9818-9822, 1990
32. Yagihashi S, Kamijo M, Ido Y, et al: Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Diabetes 39:690-696, 1990
33. +-ATPase activity in galactose-fed mice. Diabetes 39:663-666, 1990
34. Cameron NE, Leonard MB, Ross IS, et al: The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat. Diabetologia 29:168-174, 1986
35. Whiting PH, Palmano KP, Hawthorne JN: Enzymes of myo-inositol and inositol lipid metabolism in rats with streptozotocin-induced diabetes. Biochem J 179:549-553, 1979